Terazosin Hydrochloride Anhydrous
- Product NDC
- 0378-2260
- 11-digit product format
- 003782260
- Labeler code
- 0378
- Product ID
- 0378-2260_7a611827-ec05-4296-8b40-666a1a8df7da
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- terazosin hydrochloride anhydrous
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Mylan Pharmaceuticals Inc.
- Application
- ANDA075140
- Marketing category
- ANDA
- Marketing start
- 2000-02-22
- Marketing end
- 0000-00-00
- Substance
- TERAZOSIN HYDROCHLORIDE ANHYDROUS
- Active strength
- 1 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0378-2260-01 | 00378226001 | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-2260-01) | 100 capsule | 2000-02-22 | 0000-00-00 | No | No | Current |